- Published at
- by gurufocus.com
mixed
mixed
News for Leisure Acquisition Corp. (LACQU)
- Published at
- by gurufocus.com
mixedmixedEngine Capital Nominates Two Highly Qualified and Independent Candidates for Election to Lyft's Board of Directors at the 2025 Annual Meeting
\nEngine Capital LP (together with its affiliates, â\u0080\u009cEngineâ\u0080\u009d or â\u0080\u009cweâ\u0080\u009d), which owns approximately one percent of the outstanding common shares of Lyft, Inc.- Published at
- by seekingalpha.com
positivepositiveMRC Global makes board appointment in deal with Engine Capital (NYSE:MRC)
MRC Global appoints Daniel Silvers to its board in agreement with activist shareholder Engine Capital.- Published at
- by globenewswire.com
mixedmixed- Published at
- by marketscreener.com
mixedmixedEnsysce Biosciences : Announces $15 Million Convertible Note Financing (Form 8-K)
Ensysce Biosciences Announces $15 Million Convertible Note Financing SAN DIEGO, SEPTEMBER 27, 2021 - Ensysce Biosciences, Inc. , a clinical-stage biotech company with... | September 27, 2021- Published at
- by thestreet.com
mixedmixedEnsysce Biosciences Announces $15 Million Convertible Note Financing
SAN DIEGO, Sept. 27, 2021 (GLOBE NEWSWIRE) -- Ensysce Biosciences, Inc. ("Ensysce" or the "Company") (NASDAQ: ENSC, OTC: ENSCW), a clinical-stage biotech- Published at
- by globenewswire.com
mixedmixedEnsysce Biosciences Reports Second Quarter 2021 Financial Results and Recent Corporate Updates
SAN DIEGO, Aug. 16, 2021 (GLOBE NEWSWIRE) -- Ensysce Biosciences, Inc. (“Ensysce” or the “Company”) (NASDAQ: ENSC, OTC: ENSCW), a clinical-stage biotech...- Published at
- by sdbj.com
mixedmixedEnsysce Biosciences Closes SPAC Merger
Ensysce Biosciences is the latest local company to join the public market after closing the merger deal on July 1. The company will be trading its common stock...- Published at
- by thestreet.com
neutralneutralEnsysce Biosciences Receives Notice Of Award For Year Three Of Multi-Year NIDA Grant For The Clinical Development Of Its Next Generation Opioid Products With Overdose Protection
SAN DIEGO, July 08, 2021 (GLOBE NEWSWIRE) -- Ensysce Biosciences, Inc. ENSC ("Ensysce" or "the Company"), a clinical stage biotech company with proprietary- Published at
- by marketscreener.com
positivepositiveEnsysce Biosciences to Begin Trading its Common Stock on The Nasdaq Capital Market on July 2, 2021
SAN DIEGO, July 01, 2021 -- Ensysce Biosciences, Inc. today announced that the Company will begin trading its common stock under the ticker symbol “ENSC” on The Nasdaq Capital...- Published at
- by thestreet.com
positivepositiveEnsysce Biosciences To Begin Trading Its Common Stock On The Nasdaq Capital Market On July 2, 2021
SAN DIEGO, July 01, 2021 (GLOBE NEWSWIRE) -- Ensysce Biosciences, Inc. ("Ensysce" or the "Company") (NASDAQ: ENSC, OTC: ENSCW) today announced that the Company- Published at
- by thestreet.com
mixedmixedEnsysce Biosciences To Commence Trading On The OTC On July 1, 2021
SAN DIEGO, June 30, 2021 (GLOBE NEWSWIRE) -- Ensysce Biosciences, Inc. ("Ensysce" or the "Company") (OTC: LACQ, LACQW) today announced that, in connection with